Cancer cells with severe defects in mitochondrial DNA (mtDNA) can import mitochondria via horizontal mitochondrial transfer to restore respiration. Mitochondrial respiration is necessary for the activity of dihydroorotate dehydrogenase (DHODH), an enzyme of the inner mitochondrial membrane that catalyzes the fourth step of de novo pyrimidine synthesis. In this study, we investigated the role of de novo synthesis of pyrimidines in driving tumor growth in mtDNA-deficient (Ï0) cells. Although Ï0 cells grafted in mice readily acquired mtDNA, this process was delayed in cells transfected with alternative oxidase (AOX), which combines the functions of mitochondrial respiratory complexes III and IV. The Ï0 AOX cells were glycolytic but maintained normal DHODH activity and pyrimidine production. Deletion of DHODH in a panel of tumor cells completely blocked or delayed tumor growth. The grafted Ï0 cells rapidly recruited tumor-promoting/stabilizing cells of the innate immune system, including protumor M2 macrophages, neutrophils, eosinophils, and mesenchymal stromal cells (MSC). The Ï0 cells recruited MSCs early after grafting, which were potential mitochondrial donors. Grafting MSCs together with Ï0 cancer cells into mice resulted in mitochondrial transfer from MSCs to cancer cells. Overall, these findings indicate that cancer cells with compromised mitochondrial function readily acquire mtDNA from other cells in the tumor microenvironment to restore DHODH-dependent respiration and de novo pyrimidine synthesis. The inhibition of tumor growth induced by blocking DHODH supports targeting pyrimidine synthesis as a potential widely applicable therapeutic approach. SIGNIFICANCE: Mitochondrial complexes III and IV promote tumor progression by supporting de novo pyrimidine synthesis, requiring cancer cells devoid of mitochondrial DNA to recruit mitochondria from source cells to restore respiration in order to form tumors.
Mitochondrial Transfer Rescues Respiration to Support De Novo Pyrimidine Biosynthesis and Tumor Progression.
阅读:2
作者:Dubisova Maria, Bohacova Klara, Nahacka Zuzana, Kraus Daniel, Novak Jaromir, Dvorakova Sarka, Brisudova Petra, Danesova Natalie, Selvi Saba, Hrysiuk Mariia, Endaya Berwini B, Botsios Panagiotis, Le Dan-Diem Thi, Novotna Monika, Vodenkova Sona, Truksa Jaroslav, Chalupsky Karel, Klima Krystof, Prochazka Jan, Sedlacek Radislav, Mengarelli Francesco, Orlando Patrick, Tiano Luca, Boukalova Stepana, Berridge Michael V, Zobalova Renata, Neuzil Jiri
| 期刊: | Cancer Research | 影响因子: | 16.600 |
| 时间: | 2026 | 起止号: | 2026 Feb 16; 86(4):925-939 |
| doi: | 10.1158/0008-5472.CAN-24-0737 | ||
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。
